ST Engineering iDirect ‘s AI-Powered Network Analytics Platform Improves Customer Experience and Operational Performance
Anomaly detection use case will be demonstrated live with partner Q-KON at…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
Beko Presents AI-Driven Smart Appliances, Advancing Sustainability and Consumer Convenience
ISTANBUL, Sept. 5, 2025 /PRNewswire/ -- As the world's largest home and…
As Agentic AI Gains Traction, 86% of Enterprises Anticipate Heightened Risks, Yet Only 2% of Companies Meet Responsible AI Gold Standards
With 95% of enterprises facing incidents, Infosys research reveals wide gap between…
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET Â | Source: Instil Bio US phase 1…
Manufacturers and Logistics Providers Embrace AI for Enhanced Barcode Reading Performance
Survey reveals 90% of users anticipate AI will improve accuracy, ease of…